LON:DOCS Dr. Martens (DOCS) Share Forecast, Price & News GBX 127 -2.82 (-2.17%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range 125.50▼ 131.3050-Day Range 132.10▼ 171.2552-Week Range 125.50▼ 295.21Volume2.18 million shsAverage Volume2.30 million shsMarket Capitalization£1.27 billionP/E Ratio982.69Dividend Yield4.72%Price TargetGBX 221.25 ProfileProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlines Dr. Martens MarketRank™ ForecastAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside73.2% UpsideGBX 221.25 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.69Based on 7 Articles This WeekInsider TradingAcquiring Shares£1.24 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.53 out of 5 stars 3.4 Analyst's Opinion Consensus RatingDr. Martens has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 221.25, Dr. Martens has a forecasted upside of 73.2% from its current price of GBX 127.75.Amount of Analyst CoverageDr. Martens has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 1.7 Dividend Strength Dividend LeadershipDr. Martens is a leading dividend payer. It pays a dividend yield of 4.35%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthDr. Martens does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Dr. Martens is 4,615.38%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 2.6 News and Social Media Coverage News SentimentDr. Martens has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Dr. Martens this week, compared to 1 article on an average week.Search InterestOnly 12 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £12,380 in company stock and sold GBX 0 in company stock.Percentage Held by InsidersOnly 3.86% of the stock of Dr. Martens is held by insiders.Percentage Held by Institutions73.32% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Dr. Martens is 982.69, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 136.28.Price to Earnings Ratio vs. SectorThe P/E ratio of Dr. Martens is 982.69, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 423.93.Price to Earnings Growth RatioDr. Martens has a PEG Ratio of 0.04. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioDr. Martens has a P/B Ratio of 3.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Dr. Martens (LON:DOCS) StockDr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.Read More Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesJune 8, 2023 | americanbankingnews.comDr. Martens plc (LON:DOCS) Insider Buys £5,440 in StockJune 7, 2023 | americanbankingnews.comBarclays Reiterates "Overweight" Rating for Dr. Martens (LON:DOCS)June 8, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...June 6, 2023 | msn.comBarclays Reiterates Dr. Martens (DOCS) Overweight RecommendationJune 1, 2023 | thetimes.co.ukDocs smarting at profit marginsJune 1, 2023 | americanbankingnews.comDr. Martens plc (LON:DOCS) Declares Dividend of GBX 4.28June 1, 2023 | msn.comBootmaker Dr Martens' annual profit slumps as demand wanesJune 1, 2023 | nasdaq.comBootmaker Dr Martens flags hit to profit margins on higher investmentsJune 8, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...June 1, 2023 | finance.yahoo.comDr Martens tripped up by tough U.S. marketJune 1, 2023 | finance.yahoo.comUPDATE 1-Bootmaker Dr Martens flags hit to profit margins on higher investmentsJune 1, 2023 | finance.yahoo.comDr Martens warns profit margins set to fall this yearMay 31, 2023 | msn.comThese Dr. Martens boots have been a celebrity favorite for a decadeMay 30, 2023 | americanbankingnews.comDr. Martens (LON:DOCS) Downgraded to "Sector Perform" at Royal Bank of CanadaMay 23, 2023 | msn.comDr Martens sandals hurting your feet? Experts share how to break them inMay 22, 2023 | msn.comLucky thrifter scores ‘rare’ pair of Dr. Martens for a fraction of the price: ‘I’m hunting these on eBay right now’May 15, 2023 | yahoo.comThis New Yorker loves to pair an over-the-top lace skirt with chunky Dr. MartensMay 10, 2023 | yahoo.comDr. Martens Hits on Grunge Gold With the Jadon BootApril 14, 2023 | nasdaq.comUK bootmaker Dr Martens warns of lower profit as costs rise; CFO resignsApril 14, 2023 | msn.comBootmaker Dr Martens warns on profit as finance chief walksApril 14, 2023 | reuters.comUK bootmaker Dr Martens warns of lower profit as costs riseApril 14, 2023 | msn.comDr.Martens says warehouse headache led to disappointing revenue rise as hunt for new CFO beginsApril 13, 2023 | yahoo.comDr. Martens x Original Shift Document Industry Gamechangers With Limited-Edition ZineApril 10, 2023 | msn.comNext shoppers applaud 'classic and comfortable' £38 Spring sandals that look like £99 Dr MartensMarch 30, 2023 | msn.comShoppers share 'genius hack' to get money off Uggs, Dr. Martens & moreMarch 29, 2023 | msn.comLuciana Barroso’s Sexy LBD Is the Perfect Complement to Husband Matt Damon’s Doc MartensMarch 28, 2023 | nz.finance.yahoo.comThe 12 Best Ankle Boots of 2023 To Wear EverywhereSee More Headlines DOCS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Company Calendar Today6/08/2023Ex-Dividend for 7/18 Dividend6/08/2023Dividend Payable7/18/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Footwear & Accessories Sub-IndustryN/A SectorConsumer Cyclical Current SymbolLON:DOCS CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees1,897Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 221.25 High Stock Price ForecastGBX 350 Low Stock Price ForecastGBX 175 Forecasted Upside/Downside+73.2%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.13 Trailing P/E Ratio982.69 Forward P/E Ratio0.14 P/E Growth0.04Net Income£177.30 million Net MarginsN/A Pretax MarginN/A Return on Equity64.46% Return on Assets16.34% Debt Debt-to-Equity Ratio125.74 Current Ratio2.39 Quick Ratio1.13 Sales & Book Value Annual Sales£957 million Price / Sales1.33 Cash FlowGBX 8.94 per share Price / Cash Flow14.29 Book ValueGBX 35 per share Price / Book3.65Miscellaneous Outstanding Shares1,000,000,000Free FloatN/AMarket Cap£1.28 billion OptionableNot Optionable Beta0.08 Key ExecutivesMr. Kenneth Wilson (Age 56)CEO & Director Comp: $750kMr. Jon W. MortimoreCFO & DirectorMr. Geert Peeters (Age 57)Chief Operating Officer Mr. Ronald GarricksChief Information OfficerMs. Emily ReichwaldGen. Counsel & Company Sec.Ms. Meg JohnsonChief Marketing OfficerMs. Sue GannonChief HR OfficerMr. Lorenzo MorettiPres of EMEAMr. Sean O'NeillChief Digital OfficerMr. Derek ChanPres of APACMore ExecutivesKey CompetitorsMitchells & ButlersLON:MABEi Group plc (EIG.L)LON:EIG4imprint GroupLON:FOURCVS GroupLON:CVSGYouGovLON:YOUView All CompetitorsInsidersRobyn PerrissBought 5,000 shares on 6/7/2023Total: £680,000.00 ($136.00/share)Lynne WeedallBought 4,000 shares on 6/5/2023Total: £544,000.00 ($136.00/share)Jon MortimoreBought 100 shares on 3/13/2023Total: £14,000.00 ($140.00/share)Kenny WilsonBought 100 shares on 2/13/2023Total: £15,100.00 ($151.00/share)Jon MortimoreBought 72 shares on 1/11/2023Total: £14,976.00 ($208.00/share)View All Insider Transactions DOCS Stock - Frequently Asked Questions Should I buy or sell Dr. Martens stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DOCS shares. View DOCS analyst ratings or view top-rated stocks. What is Dr. Martens' stock price forecast for 2023? 4 analysts have issued 1 year target prices for Dr. Martens' shares. Their DOCS share price forecasts range from GBX 175 to GBX 350. On average, they anticipate the company's share price to reach GBX 221.25 in the next twelve months. This suggests a possible upside of 73.2% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2023? Dr. Martens' stock was trading at GBX 190.60 at the beginning of 2023. Since then, DOCS stock has decreased by 33.0% and is now trading at GBX 127.75. View the best growth stocks for 2023 here. How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens? Dr. Martens announced a dividend on Thursday, June 1st. Investors of record on Thursday, June 8th will be paid a dividend of GBX 4.28 per share on Tuesday, July 18th. This represents a yield of 2.74%. The ex-dividend date of this dividend is Thursday, June 8th. This is a boost from the stock's previous dividend of GBX 1.56. The official announcement can be accessed at this link. Read our dividend analysis for DOCS. Is Dr. Martens a good dividend stock? Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 4.35%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,615.38%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for DOCS. What is Dr. Martens' stock symbol? Dr. Martens trades on the London Stock Exchange (LON) under the ticker symbol "DOCS." How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Dr. Martens' stock price today? One share of DOCS stock can currently be purchased for approximately GBX 127.75. How much money does Dr. Martens make? Dr. Martens (LON:DOCS) has a market capitalization of £1.28 billion and generates £957 million in revenue each year. The company earns £177.30 million in net income (profit) each year or GBX 0.13 on an earnings per share basis. How many employees does Dr. Martens have? The company employs 1,897 workers across the globe. How can I contact Dr. Martens? The official website for the company is www.drmartensplc.com. The company can be reached via phone at 44 12 1415 7047. This page (LON:DOCS) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.